1
TITLE: Lebrikizumab is an effective treatment for moderate-to-severe atopic dermatitis in patients ≥60 years of age  Full Text
AUTHORS: Armstrong, April; Zirwas, Matthew; Napolitano, Maddalena; Torres, Tiago; Staumont Salle, Delphine; Atwater, Amber Reck; Dossenbach, Martin; Agell, Helena; Chen, Sherry; Qiao, Meihua; Pierce, Evangeline; Piruzeli, Maria Lucia Buziqui; Mostaghimi, Arash;
PUBLISHED: 2024, SOURCE: Revolutionizing Alopecia Areata, Vitiligo and Eczema Conference (RAVE) in BRITISH JOURNAL OF DERMATOLOGY, VOLUME: 191
INDEXED IN: WOS